The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions
Open accessAbstract
Bacterial vaginosis (BV) is the most common genital tract infection in women during their reproductive years and it has been associated with serious health complications, such as preterm delivery and acquisition or transmission of several sexually transmitted agents. BV is characterized by a reduction of beneficial lactobacilli and a significant increase in number of anaerobic bacteria, including Gardnerella vaginalis, Atopobium vaginae, Mobiluncus spp., Bacteroides spp. and Prevotella spp.. Being polymicrobial in nature, BV etiology remains unclear. However, it is certain that BV involves the presence of a thick vaginal multi-species biofilm, where G. vaginalis is the predominant species. Similar to what happens in many other biofilm-related infections, standard antibiotics, like metronidazole, are unable to fully eradicate the vaginal biofilm, which can explain the high recurrence rates of BV. Furthermore, antibiotic therapy can also cause a negative impact on the healthy vaginal microflora. These issues sparked the interest in developing alternative therapeutic strategies. This review provides a quick synopsis of the currently approved and available antibiotics for BV treatment while presenting an overview of novel strategies that are being explored for the treatment of this disorder, with special focus on natural compounds that are able to overcome biofilm-associated antibiotic resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., & Markowitz, L. E. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318074e565 · Cited by 761
The role of lactobacilli and probiotics in maintaining vaginal health
Borges, S., Silva, J., & Teixeira, P. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3064-9 · Cited by 397 · cited 2×
“…Cerca nunocerca@ceb.uminho.pt Specialty section: This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology Received: 22 October 2015 Accepted: 18 December 2015 Published: 20 January 2016 Citation: Machado D, Castro J, Palmeira-de-Oliveira A,”
BackgroundCharacterization of vaginal flora and bacterial vaginosis in women who have sex with women.
Marrazzo, J. M., Koutsky, L. A., Eschenbach, D. A., Agnew, K., Stine, K., & Hillier, S. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/339884 · Cited by 267
Probiotics for the treatment of women with bacterial vaginosis
Falagas, M. E., Betsi, G. I., & Athanasiou, S. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01688.x · Cited by 253
Vujic, G., Jajac Knez, A., Despot Stefanovic, V., & Kuzmic Vrbanovic, V. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.12.031 · Cited by 159 · cited 1×
“Diverse pharmaceutical formulations containing probiotic lactobacilli strains have reduced BV symptoms, improved the vaginal microflora profile, being usually well-tolerated (Rossi et al., 2010; Hantoushzadeh et al., 2012; Facchinetti et al., 2013; Vujic et al., 2013; Vicariotto et al., 2014).”
BackgroundIn vitro probiotic properties of Lactobacillus fermentum SK5 isolated from vagina of a healthy woman
Kaewnopparat, S., Dangmanee, N., Kaewnopparat, N., Srichana, T., Chulasiri, M., & Settharaksa, S. (2013) · Anaerobe · doi:10.1016/j.anaerobe.2013.04.009 · Cited by 126
DNase Inhibits Gardnerella vaginalis Biofilms In Vitro and In Vivo
Hymes, S. R., Randis, T. M., Sun, T. Y., & Ratner, A. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit047 · Cited by 96 · cited 1×
“In a series of in vitro studies, they showed that enzymatic disruption of extracellular DNA not only inhibited the formation of new biofilms but also destroyed the already formed ones (Hymes et al., 2013).”
BackgroundRecine, N., Palma, E., Domenici, L., Giorgini, M., Imperiale, L., Sassu, C., Musella, A., Marchetti, C., Muzii, L., & Benedetti Panici, P. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3810-2 · Cited by 88
Rossi, A., Rossi, T., Bertini, M., & Caccia, G. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1287-6 · Cited by 51
Cited by
Bacterial Biofilm and its Role in the Pathogenesis of Disease
Vestby, L. K., Grønseth, T., Simm, R., & Nesse, L. L. (2020) · Antibiotics · doi:10.3390/antibiotics9020059 · Cited by 1,105
Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health
Chee, W. J. Y., Chew, S. Y., & Than, L. T. L. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01464-4 · Cited by 657
Bacterial Biofilm Eradication Agents: A Current Review
Verderosa, A. D., Totsika, M., & Fairfull-Smith, K. E. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00824 · Cited by 555
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review
Zheng, N., Guo, R., Wang, J., Zhou, W., & Ling, Z. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.792787 · Cited by 255
He, Y., Niu, X., Wang, B., Na, R., Xiao, B., & Yang, H. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00284 · Cited by 68
Metadata
- Authors
- Machado, D., Castro, J., Palmeira-de-Oliveira, A., Martinez-de-Oliveira, J., & Cerca, N.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2016-01-20
- Volume
- 6
- Pages
- 1528-1528
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2196970383
- Cited by
- 213
- References
- 9
- FWCI
- 15.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions. https://app.cochat.ai/papers/10.3389/fmicb.2015.01528
- The paper
- Machado, D., Castro, J., Palmeira-de-Oliveira, A., Martinez-de-Oliveira, J., & Cerca, N. (2016). Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2015.01528
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.